218 related articles for article (PubMed ID: 25037912)
1. High-dose-rate interstitial brachytherapy for T1-T2-stage penile carcinoma: short-term results.
Sharma DN; Joshi NP; Gandhi AK; Haresh KP; Gupta S; Julka PK; Rath GK
Brachytherapy; 2014; 13(5):481-7. PubMed ID: 25037912
[TBL] [Abstract][Full Text] [Related]
2. Low-dose brachytherapy for early stage penile cancer: a 20-year single-institution study (73 patients).
Cordoba A; Escande A; Lopez S; Mortier L; Mirabel X; Coche-Déqueant B; Lartigau E
Radiat Oncol; 2016 Jul; 11():96. PubMed ID: 27464910
[TBL] [Abstract][Full Text] [Related]
3. Penile brachytherapy: results for 49 patients.
Crook JM; Jezioranski J; Grimard L; Esche B; Pond G
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):460-7. PubMed ID: 15890588
[TBL] [Abstract][Full Text] [Related]
4. High-dose-rate brachytherapy for localized penile cancer: Evolution of a technique.
Marbán M; Crook J; Keyes M; Dubash R; Batchelar D
Brachytherapy; 2020; 19(2):201-209. PubMed ID: 31959520
[TBL] [Abstract][Full Text] [Related]
5. High-dose-rate interstitial brachytherapy for the treatment of penile carcinoma.
Petera J; Odrázka K; Zouhar M; Bedrosová J; Dolezel M
Strahlenther Onkol; 2004 Feb; 180(2):123-5. PubMed ID: 14762666
[TBL] [Abstract][Full Text] [Related]
6. High-dose rate brachytherapy in the treatment of penile carcinoma--first experience.
Petera J; Sirák I; Kašaová L; Mačingová Z; Paluska P; Zouhar M; Kutílek P; Brod'ák M; Vošmik M
Brachytherapy; 2011; 10(2):136-40. PubMed ID: 20702142
[TBL] [Abstract][Full Text] [Related]
7. Nineteen-year single-center experience in 76 patients with penile cancer treated with high-dose-rate brachytherapy.
Kellas-Ślęczka S; Białas B; Fijałkowski M; Wojcieszek P; Szlag M; Cholewka A; Wesołowski M; Ślęczka M; Krzysztofiak T; Larysz D; Kołosza Z; Trzaska K; Pruefer A
Brachytherapy; 2019; 18(4):493-502. PubMed ID: 31101437
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
9. Organ-sparing treatment of penile cancer with interstitial pulsed-dose-rate brachytherapy.
Seibold J; Strnad V; Fietkau R
Strahlenther Onkol; 2016 Jul; 192(7):467-72. PubMed ID: 27276876
[TBL] [Abstract][Full Text] [Related]
10. [Interstitial curietherapy in penile carcinoma. Preliminary study].
Chaudary AJ; Bhavalat RL; Kulkarni JN; Sharma V; Sequeira BV
Prog Urol; 1991 Dec; 1(6):1028-33. PubMed ID: 1844733
[TBL] [Abstract][Full Text] [Related]
11. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N- or NX).
de Crevoisier R; Slimane K; Sanfilippo N; Bossi A; Albano M; Dumas I; Wibault P; Fizazi K; Gerbaulet A; Haie-Meder C
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1150-6. PubMed ID: 19395183
[TBL] [Abstract][Full Text] [Related]
13. The role of radiation therapy after incomplete resection of penile cancer.
Langsenlehner T; Mayer R; Quehenberger F; Prettenhofer U; Langsenlehner U; Pummer K; Kapp KS
Strahlenther Onkol; 2008 Jul; 184(7):359-63. PubMed ID: 19016034
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome and toxicity in a Phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer.
Kaufman SA; DiPetrillo TA; Price LL; Midle JB; Wazer DE
Brachytherapy; 2007; 6(4):286-92. PubMed ID: 17991625
[TBL] [Abstract][Full Text] [Related]
15. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
[TBL] [Abstract][Full Text] [Related]
16. Comparison of efficacy and safety of low-dose-rate vs. high-dose-rate intraluminal brachytherapy boost in patients with superficial esophageal cancer.
Tamaki T; Ishikawa H; Takahashi T; Tamaki Y; Kitamoto Y; Okamoto M; Noda SE; Katoh H; Shirai K; Sakurai H; Nakano T
Brachytherapy; 2012; 11(2):130-6. PubMed ID: 21700506
[TBL] [Abstract][Full Text] [Related]
17. High-dose-rate brachytherapy in uterine cervical carcinoma.
Patel FD; Rai B; Mallick I; Sharma SC
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
[TBL] [Abstract][Full Text] [Related]
18. The role of pulsed-dose-rate brachytherapy in previously irradiated head-and-neck cancer.
Strnad V; Geiger M; Lotter M; Sauer R
Brachytherapy; 2003; 2(3):158-63. PubMed ID: 15062138
[TBL] [Abstract][Full Text] [Related]
19. Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma: an evaluation of long-term outcome.
Thiagarajan A; Lin K; Tiong CE; Tan LK; Loh TK; Goh BC; Lu JJ
Laryngoscope; 2006 Jun; 116(6):938-43. PubMed ID: 16735885
[TBL] [Abstract][Full Text] [Related]
20. Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.
Lettmaier S; Lotter M; Kreppner S; Strnad A; Fietkau R; Strnad V
Radiother Oncol; 2012 Aug; 104(2):181-6. PubMed ID: 22853851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
